Tagariello G, Castaman G, Falanga A, Santoro R, Napolitano M, Storti S, Veneri D, Basso M, Candiotto L, Tassinari C, Federici AB, De Stefano V; GIMEMA Haemostasis and Thrombosis working party.
Blood Transfus. 2016 Nov;14(6):521-526.
Pubblicazioni 2016
Thrombophilic status may predict prognosis in patients with metastatic BRAFV600-mutated melanoma who are receiving BRAF inhibitors
Falanga A, Marchetti M, Massi D, Merelli B, Verzeroli C, Russo L, Rulli E, Tondini C, Legramandi L, Nassini R, Scatena C, De Logu F, Cattaneo L, Mandalà M.
J Am Acad Dermatol. 2016;74(6):1254-1256.e4.
A Validated Risk Score for Venous Thromboembolism Is Predictive of Cancer Progression and Mortality
Kuderer NM, Culakova E, Lyman GH, Francis C, Falanga A, Khorana AA.
Oncologist. 2016;21(7):861-7.
Molecular biomarkers of thrombosis in myeloproliferative neoplasms
Hypercoagulation screening as an innovative tool for risk assessment, early diagnosis and prognosis in cancer: the HYPERCAN study
Falanga A, Santoro A, Labianca R, De Braud F, Gasparini G, D’Alessio A, Barni S, Iacoviello L; HYPERCAN Study Group.
Thromb Res. 2016;140 Suppl 1:S55-9.